Neuroendocrine carcinoma is a rare and highly aggressive form of cancer that originates from neuroendocrine cells, which possess characteristics of both nerve cells and hormone-producing cells. Market Overview and Key StatisticsThe Neuroendocrine Carcinoma Market size is expected to reach US$ 4.05 Billion by 2031. The market is anticipated to register a CAGR of 8.6% during 2025–2031. This...